1256 related articles for article (PubMed ID: 21398042)
1. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
[TBL] [Abstract][Full Text] [Related]
3. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.
Lee SW; Kim WJ; Choi YK; Song HS; Son MJ; Gelman IH; Kim YJ; Kim KW
Nat Med; 2003 Jul; 9(7):900-6. PubMed ID: 12808449
[TBL] [Abstract][Full Text] [Related]
4. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
5. [Disruption of blood brain-barrier by leukemic cells in central nervous system leukemia].
Feng SR; Chen ZX; Cen JN; Shen HJ; Wang YY; Yao L
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):289-93. PubMed ID: 21729594
[TBL] [Abstract][Full Text] [Related]
6. [Critical roles of matrix metalloproteinases secreted by leukemic cells in the pathogenesis of central nervous system leukemia].
Feng SR; Chen ZX; Cen JN; Shen HJ; Wang YY; Yao L
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1070-1076. PubMed ID: 28088972
[TBL] [Abstract][Full Text] [Related]
7. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
[TBL] [Abstract][Full Text] [Related]
8. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels.
Date I; Takagi N; Takagi K; Tanonaka K; Funakoshi H; Matsumoto K; Nakamura T; Takeo S
Neurosci Lett; 2006 Oct; 407(2):141-5. PubMed ID: 16973272
[TBL] [Abstract][Full Text] [Related]
10. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
[TBL] [Abstract][Full Text] [Related]
12. Role of VEGF in an experimental model of cortical micronecrosis.
Lafuente JV; Bulnes S; Mitre B; Riese HH
Amino Acids; 2002; 23(1-3):241-5. PubMed ID: 12373544
[TBL] [Abstract][Full Text] [Related]
13. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells.
Spoerri PE; Afzal A; Li Calzi S; Shaw LC; Cai J; Pan H; Boulton M; Grant MB
Mol Vis; 2006 Jan; 12():32-42. PubMed ID: 16446700
[TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier/neurovascular unit in health and disease.
Hawkins BT; Davis TP
Pharmacol Rev; 2005 Jun; 57(2):173-85. PubMed ID: 15914466
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2.
Lee SW; Kim WJ; Jun HO; Choi YK; Kim KW
Int J Mol Med; 2009 Feb; 23(2):279-84. PubMed ID: 19148554
[TBL] [Abstract][Full Text] [Related]
16. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
18. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
[TBL] [Abstract][Full Text] [Related]
19. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
[TBL] [Abstract][Full Text] [Related]
20. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
Nag S; Venugopalan R; Stewart DJ
Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
